- BNF:
- 11.6
- Status:
- Do Not Prescribe (DNP), Grey - after consultant/specialist recommendation
- Decision Date:
- July 2019
Comments
GREY after consultant/specialist initiation: 2nd line prostaglandin analogue. (40micrograms/ml eye drops). Cost effective to prescribe generically. (Decision date - July 2022)
DNP: Not to be prescribed by brand - Travatan. (Decision date - August 2019)
search again